Cipla Limited v. Novartis AG and Ors. 2017 (70) PTC 80 (Del) Respondents (Novartis AG and Ors.) filed a suit for permanent injunction seeking to restrain the Appellant (Cipla Ltd.) from infringing its Patent. Along with the suit, Respondents had also filed an application for interim relief of temporary injunction during the pendency of the…
NOVARTIS AG & ORS. v. INTAS PHARMACEUTICALS LTD. I.A. No. 8421 of 2015 in CS(OS) No. 1120/2015 IN THE HIGH COURT OF DELHI AT NEW DELHI Date of Order: 24.04.2015 Prima Facie Facts: • Plaintiffs were engaged in the business of manufacturing and sale of ranibizumab. Plaintiffs also conducted clinical data and scientific research by…
Novartis AG and Anr. v. Cipla Ltd. I.A. No.24863/2014 IN CS(OS) No. 3812/2014 Date of decision: 09.01.2015 Delhi High Court Plaintiff held a Patent for INDACATEROL (for Chronic Obstructive Pulmonary Disease). Plaintiff filed a suit against the Defendant towards infringement of the said Patent. On 22nd October, 2014 the Defendant made a representation to the…
Ranbaxy Laboratories Ltd. v. Novartis AG & Anr. Before the High Court of Delhi at New Delhi Date of Decision: 18.10.2014 FAO(OS) No. 447 of 2014 Respondents had filed a suit for permanent injunction restraining the appellant from infringing Respondents’ Patent. The suit along with the application for interim relief came up for preliminary consideration…
NOVARTIS AG AND ORS. v. RANBAXY LABORATORIES LTD. 08.09.2014 In The High Court of Delhi Plaintiffs filed a suit against the Defendant towards infringement of it’s Patent being Patent No. 212815 for active pharmaceutical ingredient called Vildagliptin which treats Type 2 Diabetes Mellitus marketed as GALVUS and GALVUSMET. Plaintiffs’ Case: Defendant has included Plaintiffs’ patented…